BMO GLBL CONSUMER DISCRETION (DISC.CA) Stock News
TSX:DISC - Toronto Stock Exchange - CA05584F1099 - ETF - Currency: CAD
DISC.CA Latest News, Press Relases and Analysis
All
Press Releases
a year ago - Benzinga
Disc Medicine Stock Plunges As Light Sensitivity Treatment Data Confounded Due To Outsized Placebo Response
Disc Medicine releases AURORA Phase 2 study data on bitopertin for Erythropoietic Protoporphyria. Significant reductions in PPIX levels and improvements in phototoxic reactions observed with bitopertin treatment.